|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print May 16, 2002
Am J Physiol Heart Circ Physiol, 10.1152/ajpheart.00148.2002
Submitted on February 25, 2002
Accepted on May 13, 2002
1 Departments of Ob/Gyn and Physiology, University of Alberta, Edmonton, Alberta, Canada
* To whom correspondence should be addressed. E-mail: sandra.davidge{at}ualberta.ca.
The reduction in estrogen in postmenopausal women contributes to an increase in vascular dysfunction. Models of aging have shown that this is due, in part, to increased prostaglandin H synthase (PGHS)-dependent vasoconstriction. We had previously shown that inducible PGHS-2-dependent vasoconstriction is increased with aging. In this study, we hypothesized that estrogen suppresses PGHS-2-dependent constriction in the aged rat. Isolated mesenteric arteries from placebo or estrogen-treated ovariectomized, aged (24 months) Fisher rats were assessed for endothelium-dependent relaxation in the absence or presence of PGHS inhibitors. PGHS inhibition (meclofenamate, 1 µmol/L) enhanced methacholine-induced relaxation in only the placebo group. Specific PGHS-2 inhibition (NS-398, 10 µmol/L) increased arterial relaxation to a greater extent than PGHS-1 inhibition (valeryl salicylate, 3 mmol/L). Estrogen prevented the PGHS-dependent constrictor effect but did not enhance nitric oxide-dependent relaxation in this model. PGHS-1 and endothelial nitric oxide synthase were not altered by estrogen while PGHS-2 expression was decreased in the estrogen-replaced rats (P<0.05). In summary, estrogen replacement improved vasodilation in aged rats by decreasing PGHS-dependent constriction.
This article has been cited by other articles:
![]() |
A. J. LeBlanc, R. Reyes, L. S. Kang, R. A. Dailey, J. N. Stallone, N. C. Moningka, and J. M. Muller-Delp Estrogen replacement restores flow-induced vasodilation in coronary arterioles of aged and ovariectomized rats Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2009; 297(6): R1713 - R1723. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Arenas, S. J. Armstrong, Y. Xu, and S. T. Davidge Tumor Necrosis Factor-{alpha} and Vascular Angiotensin II in Estrogen-Deficient Rats Hypertension, September 1, 2006; 48(3): 497 - 503. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Arenas, Y. Xu, and S. T. Davidge Age-associated impairment in vasorelaxation to fluid shear stress in the female vasculature is improved by TNF-{alpha} antagonism Am J Physiol Heart Circ Physiol, March 1, 2006; 290(3): H1259 - H1263. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Arenas, S. J. Armstrong, Y. Xu, and S. T. Davidge Chronic Tumor Necrosis Factor-{alpha} Inhibition Enhances NO Modulation of Vascular Function in Estrogen-Deficient Rats Hypertension, July 1, 2005; 46(1): 76 - 81. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xu, S. J. Armstrong, I. A. Arenas, D. J. Pehowich, and S. T. Davidge Cardioprotection by chronic estrogen or superoxide dismutase mimetic treatment in the aged female rat Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H165 - H171. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J Armstrong, Y. Xu, and S. T Davidge Effects of chronic PGHS-2 inhibition on PGHS-dependent vasoconstriction in the aged female rat Cardiovasc Res, February 1, 2004; 61(2): 333 - 338. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |